Author

Nóra M. Márkus

University of SheffieldORCID 0000-0001-8423-029XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Organism:Drosophila· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:protein structure· 1

Frequent Co-Authors

Laura FerraiuoloiD· 2 shared Raquel Rua MartinsiD· 2 shared Richard J. MeadiD· 2 shared Adrian Higginbottom· 1 shared Alexander J. WhitworthiD· 1 shared Allan Christian ShawiD· 1 shared Álvaro Sánchez-MartíneziD· 1 shared Amy F. A. KeerieiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Laura FerraiuoloORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeurosciencebioRxivPreprintMar 6, 2025

Artificial intelligence-augmented drug discovery identifies gefitinib as a potential treatment for ALS

Monika A. Myszczynska, Matthew J. Stopford, Nóra M. Márkus…·Laura Ferraiuolo

This paper uses AI to identify gefitinib as a potential ALS treatment, showing it protects motor neurons and reduces TDP-43 fragments in vitro and in vivo.

2 citations

humanmouse

𝕏 PostBluesky

Molecular BiologyScience Translational MedicinePeer-reviewedMar 1, 2023

A cell-penetrant peptide blocking C9ORF72-repeat RNA nuclear export suppresses neurodegeneration

Lydia M. Castelli, Ya-Hui Lin, Álvaro Sánchez-Martínez…·Guillaume M. Hautbergue

This paper develops a cell-penetrant peptide that blocks C9ORF72-repeat RNA nuclear export, reducing neurodegeneration in preclinical models of ALS and FTD.

16 citations

humanDrosophila

𝕏 PostBluesky